Equities

Indofarma Tbk PT

INAF:JKT

Indofarma Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)163.00
  • Today's Change29.00 / 21.64%
  • Shares traded247.30k
  • 1 Year change-76.20%
  • Beta-0.4869
Data delayed at least 10 minutes, as of May 08 2024 10:07 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • INAF:JKT price moved over +5.00% to 147.00

Key statistics

On Wednesday, Indofarma Tbk PT (INAF:JKT) closed at 163.00, 25.38% above the 52 week low of 130.00 set on May 02, 2024.
52-week range
Today
130.00May 02 2024725.00Dec 21 2023
Open154.00
High163.00
Low154.00
Bid436.00
Offer436.00
Previous close134.00
Average volume151.99k
Shares outstanding3.10bn
Free float599.27m
P/E (TTM)--
Market cap505.18bn IDR
EPS (TTM)-141.03
IDR
Data delayed at least 10 minutes, as of May 08 2024 10:07 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.